GLATECT

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 53bb3573127d8988
Drug Approval Canada Name: GLATECT
Product Name: GLATECT
Status: Marketed
Status Date: 2017-08-21
Original Market Date: 2017-08-21
Din: 02460661
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription
Ahfs: 92:20.00
Atc Original: L03AX13 GLATIRAMER ACETATE
Atc Name: l 03 ax 13
Aig Number: 0132525001
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

GLATIRAMER ACETATE

20 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

53bb3573127d8988

Type

Standard